Publications by authors named "F Mnif"
Introduction: Metabolic syndrome (MS) is responsible for the increased cardiovascular risk in patients with type 2 diabetes. Few studies have focused on MS in type 1 diabetes mellitus (T1DM).
Aim: To describe the clinical, biochemical and therapeutic characteristics of T1DM patients affected by MS.
Metabolic Disorders During Prolactinomas.
Metab Syndr Relat Disord
March 2024
Article Synopsis
- The study examined metabolic changes in 77 patients with prolactinomas, focusing on the relationship between tumor size and various metabolic parameters.
- Key findings revealed that larger prolactinomas were associated with higher waist circumference and increased instances of obesity, glucose tolerance issues, and hypertriglyceridemia.
- The results suggest that assessing metabolic health is crucial for the management of prolactinomas, especially as metabolic syndrome is more prevalent in patients with larger tumors.
Background: Pituitary apoplexy (PA) is defined as the hemorrhage or the infraction of a pituitary adenoma. Aiming to determine the epidemiological, clinical, paraclinical characteristics as well as management and outcomes of PA in our population, we conducted this cross-sectional study.
Methods: This cross-sectional study was conducted at the Department of Endocrinology of Hedi chaker university hospital, Sfax.
Summary: A 55-year-old patient was admitted to our department for the management of a repetitive alteration of consciousness. Biological investigation results were consistent with endogenous hyperinsulinemic hypoglycemia. Insulinoma was therefore suspected.
View Article and Find Full Text PDFArticle Synopsis
- A 42-year-old woman exhibited severe health issues, including high blood pressure (grade three hypertension), low potassium levels (severe hypokalemia), and absence of menstrual periods (primary amenorrhea).
- Doctors diagnosed her with complete 17 alpha-hydroxylase deficiency, a rare hormonal disorder.
- The case report covers the difficult treatment options, the patient's outcomes, and the follow-up process after diagnosis.